Navigation Links
Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil

Technology incorporates naturally occurring soil micro-organism proteins to protect cotton plantations

INDIANAPOLIS and SAO PAULO, March 19 /PRNewswire/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announced that it has received regulatory approval from the Brazilian National Technical Commission of Biosafety (CTNBio), for its WideStrike(TM) Insect Protection technology in cotton in Brazil. WideStrike, currently marketed in the United States, provides season-long, whole-plant protection from insect feeding cotton pests.

The WideStrike technology uses two insect resistant traits that effectively control important cotton pests especially the Spodoptera frugiperda, Heliothis virescens, Pectinophora gossypiella, and the Alabama argillacea pests. Studies conducted by Dow AgroSciences and analyzed by CTNBio show that WideStrike does not create unreasonable risk to humans or the environment.

"The cultivation of cotton has gained strength in recent years in Brazil for its fiber," said Rolando Alegria, Seeds and Biotechnology director, Dow AgroSciences in Brazil. "Additionally, WideStrike contributes to a more sustainable agriculture because it controls the most harmful pests to cotton plantations. Dow AgroSciences will now be able to provide access to its company's technologies - which are among the most advanced of the world - to a larger number of growers."

Before becoming available in the Brazilian market, this technology has gone through rigorous testing in several regions of the country, and also has been tested in laboratories.

Cottonseed containing this technology has been planted since 2004 in the United States where the oil and meal produced from WideStrike cottonseed has been approved for use in human food and animal feed. These products have also been approved for use in human food and animal feed in Canada and in Japan, as well as for in human food in Mexico, South Korea, and Australia.

In December 2008, CTNBio granted its approval to Dow AgroSciences for HERCULEX(R) I Insect Protection technology that provides protection against the main corn pest in Brazil, the sugar cane borer and fall armyworm (Spodoptera frugiperda). The commercialization of the HERCULEX I hybrid corn seeds, which also produces a Bt protein to protect the plant, has already been approved by the Brazilian Ministry of Agriculture.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at

(TM)(R)HERCULEX and WideStrike are registered trademarks of Dow AgroSciences LLC

SOURCE Dow AgroSciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
2. Dow AgroSciences Delivering Beyond Expectations
3. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
4. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
7. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
8. Dow AgroSciences Success Presented to Wall Street
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
11. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International Society ... one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The ... where ISPE hosted the largest number of attendees in more than a decade. ...
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
(Date:10/29/2015)...  Connected health pioneer, Joseph C. Kvedar , ... health and wellness, and the business opportunities that arise ... Internet of Healthy Things . Long before health ... Dr. Kvedar, vice president, Connected Health, Partners HealthCare, was ... care from the hospital or doctor,s office into the ...
Breaking Biology News(10 mins):